$1.275
-0.048 (-3.77%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PMVP Prediction & Forecast by Similar Chart Analysis
Alphio's PMVP stock price prediction model matches the current PMV Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.29 (+1.21%). The 1-week path is $1.30 (+1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy PMV Pharmaceuticals Inc Stock?
PMV Pharmaceuticals Inc is a good buy right now due to its current price of $1.37, which is significantly below the analyst price target of $3. Additionally, the stock has shown a strong 5-day change of +21.24%, indicating positive momentum. The upcoming New Drug Application submission for Rezatapopt in Q1 2027 could serve as a major catalyst for price appreciation. However, the company faces a risk with a projected EPS of -0.31 for the next earnings date, indicating ongoing losses.
PMVP stock price ended at $1.28 on Thursday, after losing -3.77%
PMV Pharmaceuticals Inc (PMVP) last closed at $1.275, losing -3.77%. These facts feed the 1-day and 1-week PMVP price prediction above.
Forecast Drivers
PMV Pharmaceuticals Inc (PMVP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PMVP, ranked by similarity.
Seasonality analysis for PMVP
Historically the probability of a positive November return for PMVP is 9.30%. September offers the highest probability of a positive month at 37.10%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PMVP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.19 | $1.24 | $1.41 | -3.08% |
| Dec 2026 | $1.58 | $1.59 | $1.76 | +24.56% |
In 2026, PMV Pharmaceuticals Inc (PMVP) is projected to range from $1.19 to $1.76.
PMV Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, PMV Pharmaceuticals Inc is projected to average $1.24, with a low of $1.19 and high of $1.41.
In Dec 2026, PMV Pharmaceuticals Inc is projected to average $1.59, with a low of $1.58 and high of $1.76.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.